Tactile Systems Technology Inc (TCMD) - Total Liabilities
Based on the latest financial reports, Tactile Systems Technology Inc (TCMD) has total liabilities worth $54.23 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Tactile Systems Technology Inc cash flow conversion to assess how effectively this company generates cash.
Tactile Systems Technology Inc - Total Liabilities Trend (2013–2024)
This chart illustrates how Tactile Systems Technology Inc's total liabilities have evolved over time, based on quarterly financial data. Check TCMD asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Tactile Systems Technology Inc Competitors by Total Liabilities
The table below lists competitors of Tactile Systems Technology Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Canada Goose Holdings Inc
TO:GOOS
|
Canada | CA$1.22 Billion |
|
Sinocat Environmental Technology Co Ltd
SHG:688737
|
China | CN¥1.57 Billion |
|
Nam Long Investment Corp
VN:NLG
|
Vietnam | ₫14.00 Trillion |
|
Shandong Lipeng Co Ltd
SHE:002374
|
China | CN¥2.42 Billion |
|
Kearny Financial Corp
NASDAQ:KRNY
|
USA | $6.86 Billion |
|
Cementos Bio-B
SN:CEMENTOS
|
Chile | CL$239.33 Billion |
|
TSRC Corp
TW:2103
|
Taiwan | NT$20.76 Billion |
|
Medigen Vaccine Biologics
TWO:6547
|
Taiwan | NT$454.64 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Tactile Systems Technology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TCMD stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.61 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tactile Systems Technology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tactile Systems Technology Inc (2013–2024)
The table below shows the annual total liabilities of Tactile Systems Technology Inc from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $81.33 Million | -7.37% |
| 2023-12-31 | $87.80 Million | -34.28% |
| 2022-12-31 | $133.60 Million | +15.13% |
| 2021-12-31 | $116.04 Million | +135.20% |
| 2020-12-31 | $49.34 Million | +26.00% |
| 2019-12-31 | $39.16 Million | +119.97% |
| 2018-12-31 | $17.80 Million | +13.67% |
| 2017-12-31 | $15.66 Million | +9.54% |
| 2016-12-31 | $14.30 Million | +47.46% |
| 2015-12-31 | $9.70 Million | +41.76% |
| 2014-12-31 | $6.84 Million | -2.56% |
| 2013-12-31 | $7.02 Million | -- |
About Tactile Systems Technology Inc
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as l… Read more